Abstract

BackgroundHOX cofactors enhance HOX binding affinities and specificities and increase HOX's unique functional activities. The expression and the regulation of HOX cofactors in human ovaries are unknown.MethodsIn this study, the expression of HOX cofactors, PBX1, PBX2, and MEIS1/2, were examined by using RT-PCR, immunofluorescence in cultured immortalized human granulosa (SVOG) cells. The distribution of these HOX cofactors in human ovaries was examined by immunohistochemistry. The effects of growth differentiation factor-9 (GDF-9) and follicle-stimulating hormone (FSH) on PBX2 in SVOG cells were investigated by western blot analysis. Binding activities of HOXA7 and PBX2 to the specific sequences in granulosa cells were determined by electrophoretic mobility shift assay (EMSA).Results and conclusionIn SVOG cells, PBX1, PBX2 and MEIS1/2 were expressed during cell culture. In normal human ovaries, PBX1 and MEIS1/2 were expressed in granulosa cells at essentially all stages of follicular development. These cofactors were expressed in the nuclei of the granulosa cells from the primordial to the secondary follicles, whereas beyond multilayered follicles was observed in the cytoplasm. The co-expression of PBX1 and MEIS1/2 in granulosa cells in normal human ovaries suggested that MEIS1/2 might control PBX1 sublocalization, as seen in other systems. PBX2 was not expressed or weakly expressed in the primordial follicles. From the primary follicles to the preovulatory follicles, PBX2 expression was inconsistent and the expression was found in the granulosa cell nuclei. The PBX2 expression pattern is similar to HOXA7 expression in ovarian follicular development. Furthermore, FSH down-regulated, GDF-9 did not change PBX2 expression, but co-treatment of the granulosa cells with FSH and GDF-9 up-regulated PBX2 expression. These results implicated a role for PBX2 expression in the steroidogenic activities of granulosa cells in humans. Moreover, PBX2 and HOXA7 bound together to the Pbx sequence, but not to the EMX2 promoter sequence, in SVOG cells. Our findings indicate that HOX cofactors expression in normal human ovary is temporally and spatially specific and regulated by FSH and GDF-9 in granulosa cells. HOX proteins may use different HOX cofactors, depending on DNA sequences that are specific to the granulosa cells.

Highlights

  • HOX cofactors enhance HOX binding affinities and specificities and increase HOX's unique functional activities

  • Because PBX2 expression was observed to be similar to HOXA7 as seen in our previous study [3], we focused on PBX2 and investigated the regulation of PBX2 by folliclestimulating hormone (FSH) and growth differentiation factor-9 (GDF-9) treatment and on the DNA binding activities of PBX2 and HOXA7 in granulosa cells

  • Expression of HOX cofactors in immortalized granulosa cells Recent studies have identified a number of HOX genes in the oocytes, and we have previously shown the distribution of HOXA7 in ovarian follicular development [3]

Read more

Summary

Introduction

HOX cofactors enhance HOX binding affinities and specificities and increase HOX's unique functional activities. The expression and the regulation of HOX cofactors in human ovaries are unknown. Transcription factors play important roles in oogenesis and folliculogenesis [1,2]. Numerous studies have emphasized the importance of ovarian-specific transcription factor genes during ovarian follicular development. Non-ovarian-specific genes are expressed during ovarian follicular development, and their potential functions in folliculogenesis, such as steroidogenesis, are not known [3,4,5]. Immunohistochemical studies have shown that, in newborn female reproductive systems, Meis is expressed throughout the ovary, uterus, cervix and vagina [8]. MEIS1 and MEIS2 are expressed in the nuclei of normal adult human ovarian surface epithelium; their functions in the ovary have not been elucidated [21]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.